Allianz Asset Management’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.21M | Sell |
5,300
-648
| -11% | -$145K | ﹤0.01% | 1684 |
|
|
2025
Q4 | $1.27M | Sell |
5,948
-2,376
| -29% | -$491K | ﹤0.01% | 1656 |
|
|
2025
Q3 | $1.65M | Sell |
8,324
-976
| -10% | -$182K | ﹤0.01% | 1566 |
|
|
2025
Q2 | $1.61M | Buy |
9,300
+5,500
| +145% | +$896K | ﹤0.01% | 1543 |
|
|
2025
Q1 | $592K | Sell |
3,800
-175
| -4% | -$25K | ﹤0.01% | 1825 |
|
|
2024
Q4 | $547K | Buy |
3,975
+8
| +0.2% | +$1.05K | ﹤0.01% | 1837 |
|
|
2024
Q3 | $592K | Buy |
3,967
+200
| +5% | +$27K | ﹤0.01% | 1811 |
|
|
2024
Q2 | $514K | Buy |
3,767
+4
| +0.1% | +$544 | ﹤0.01% | 1825 |
|
|
2024
Q1 | $569K | Buy |
3,763
+163
| +5% | +$23.3K | ﹤0.01% | 1580 |
|
|
2023
Q4 | $453K | Buy |
+3,600
| New | +$359K | ﹤0.01% | 1882 |
|
|
2023
Q2 | – | Sell |
-11,200
| Closed | -$1.2M | – | 2152 |
|
|
2023
Q1 | $1.2M | Buy |
+11,200
| New | +$1.28M | ﹤0.01% | 1616 |
|
|
2022
Q3 | – | Sell |
-18,105
| Closed | -$1.68M | – | 1892 |
|
|
2022
Q2 | $1.68M | Hold |
18,105
| – | – | ﹤0.01% | 1483 |
|
|
2022
Q1 | $2.13M | Sell |
18,105
-34,910
| -66% | -$4.04M | ﹤0.01% | 1573 |
|
|
2021
Q4 | $7.15M | Buy |
53,015
+9,355
| +21% | +$1.39M | 0.01% | 1109 |
|
|
2021
Q3 | $6.96M | Buy |
43,660
+26,765
| +158% | +$3.66M | 0.01% | 1151 |
|
|
2021
Q2 | $2.22M | Sell |
16,895
-15,330
| -48% | -$2.04M | ﹤0.01% | 1430 |
|
|
2021
Q1 | $4.15M | Sell |
32,225
-2,245
| -7% | -$341K | ﹤0.01% | 1142 |
|
|
2020
Q4 | $5.75M | Hold |
34,470
| – | – | 0.01% | 1000 |
|
|
2020
Q3 | $5.32M | Sell |
34,470
-4,270
| -11% | -$614K | 0.01% | 963 |
|
|
2020
Q2 | $5.73M | Buy |
38,740
+1,645
| +4% | +$226K | 0.01% | 1148 |
|
|
2020
Q1 | $4.18M | Sell |
37,095
-1,385
| -4% | -$180K | 0.01% | 1230 |
|
|
2019
Q4 | $5.35M | Sell |
38,480
-2,825
| -7% | -$314K | 0.01% | 1455 |
|
|
2019
Q3 | $3.98M | Sell |
41,305
-13,055
| -24% | -$1.46M | ﹤0.01% | 1554 |
|
|
2019
Q2 | $6.26M | Sell |
54,360
-3,070
| -5% | -$367K | 0.01% | 1395 |
|
|
2019
Q1 | $6.76M | Buy |
57,430
+13,610
| +31% | +$1.19M | 0.01% | 1313 |
|
|
2018
Q4 | $2.69M | Sell |
43,820
-34,300
| -44% | -$2.16M | ﹤0.01% | 1647 |
|
|
2018
Q3 | $5.54M | Sell |
78,120
-69,340
| -47% | -$4.77M | 0.01% | 1516 |
|
|
2018
Q2 | $9.81M | Sell |
147,460
-31,260
| -17% | -$2.06M | 0.01% | 1258 |
|
|
2018
Q1 | $11.7M | Buy |
178,720
+350
| +0.2% | +$19.7K | 0.01% | 1175 |
|
|
2017
Q4 | $7.14M | Buy |
178,370
+57,920
| +48% | +$2.11M | 0.01% | 1481 |
|
|
2017
Q3 | $4.37M | Buy |
+120,450
| New | +$3.46M | 0.01% | 1682 |
|
Other funds holding ASND
RCM
ACA
